The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct

BACKGROUND: It is hypothesized that in individuals without clinical cardiovascular disease (CVD), but at increased CVD risk, a 50% to 60% reduction in CVD risk could be achieved using fixed dose combination (FDC) therapy (usually comprised of multiple blood-pressure agents and a statin [with or with...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Philip, Pais, Prem, Dans, Antonio L, Bosch, Jackie, Xavier, Denis, Lopez-Jaramillo, Patricio, Yusoff, Khalid, Santoso, Anwar, Talukder, Shamim, Gamra, Habib, Yeates, Karen, Lopez, Paul Camacho, Tyrwhitt, Jessica, Gao, Peggy, Teo, Koon, Yusuf, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299262/
https://www.ncbi.nlm.nih.gov/pubmed/30342297
http://dx.doi.org/10.1016/j.ahj.2018.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299262/
https://www.ncbi.nlm.nih.gov/pubmed/30342297
http://dx.doi.org/10.1016/j.ahj.2018.07.012

Ejemplares similares